Apeiron Synthesis S.A.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Apeiron Synthesis S.A. - overview
Established
2009
Location
Wroclaw, -, Poland
Primary Industry
Chemicals
About
Based in Wrocław, Poland, and founded in 2009 Apeiron Synthesis S. A. provides olefin methatesis technology to the chemical industry. In December 2022, the firm raised USD 4.
8 million in venture funding from investors Adamed Pharma S. A. , Aper Ventures, and Orlen VC. The company was founded by Dr.
Michal Bieniek (CEO), Lukasz Gulajski, Krzysztof Skowerski, and Prof. Karol Grela MAE. The company offers a wide range of services such as Olefin metathesis consulting, catalysts screening, process development, custom catalyst development, product development, and kilo-scale synthesis. Additionally, the firm provides catalysts and polymers which include nitro – Grela, UltraLatMet, UltraCat, UltraNitroCat, ROMP catalysts, and many more.
The firm catalyst is used in pharmaceuticals, flavors, and fragrances as well as in the production of polymers and rubber. The firm customer base includes 279 clients and has delivered 25 commercial projects.
Current Investors
Adamed Pharma S.A., Orlen VC, Aper Ventures
Primary Industry
Chemicals
Sub Industries
Chemicals
Website
http://www.apeiron-synthesis.com
Verticals
Manufacturing
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Apeiron Synthesis S.A. - timeline of key events
Apeiron Synthesis S.A. - financials
| Fiscal Year Ended | Dec 31, 2017 | Dec 31, 2018 | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|---|---|
| Revenue (USD) | 1,188,637.7 | 1,230,771.9 | 4,717,263.3 | 2,315,856.2 | - | - | - |
| % Revenue Growth (YoY) | - | 3.5% | 283.3% | (50.9%) | - | - | - |
| EBITDA (USD) | (1,080,644.3) | (1,104,806.8) | 1,284,751.6 | (1,566,602.8) | - | - | - |
| Operating Income (USD) | (1,347,025.7) | (1,336,570.5) | 554,026.9 | (2,374,992.9) | - | - | - |
| Operating Margin | (113.3%) | (108.6%) | 11.7% | (102.6%) | - | - | - |
| % EBITDA Margin | (90.9%) | (89.8%) | 27.2% | (67.6%) | - | - | - |
| NET Income (USD) | (1,323,797) | (1,265,980.8) | 833,359.8 | (2,419,929.9) | - | - | - |
| % Net Margin | (111.4%) | (102.9%) | 17.7% | (104.5%) | - | - | - |
Apeiron Synthesis S.A. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.